Evidence map›Paper›PMID 33145014›Full record

ArticleF1000Research2020

Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases.

Morgan K Groover, Jillian M Richmond

Open access · goldAbstract read
In one paragraph

Article in F1000Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Morgan K GrooverDepartment of Dermatology, University of Massachussetts Medical School, Worcester, MA, 01605, USA.ORCID 0000-0003-1292-4393
Jillian M RichmondDepartment of Dermatology, University of Massachussetts Medical School, Worcester, MA, 01605, USA.ORCID 0000-0003-1589-6770
University of Massachusetts Chan Medical School · US

Funding

Defining dysregulated immune and fibrotic pathways in morpheaR56AR075761 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JACOBE, HEIDI T, TOROK, KATHRYN S. · 2019 to 2019
$289k
NIAMS NIH HHS R56 AR075761
6 · The paper itself

Abstract

Chemokines play important roles in homeostasis and inflammatory processes. While their roles in leukocyte recruitment are well-appreciated, chemokines play additional roles in the body, including mediating or regulating angiogenesis, tumor metastasis and wound healing. In this opinion article, we focus on the role of CXCR3 and its ligands in fibrotic processes. We emphasize differences of the effects of each ligand, CXCL9, CXCL10 and CXCL11, on fibroblasts in different tissues of the body. We include discussions of differences in signaling pathways that may account for protective or pro-fibrotic effects of each ligand in different experimental models and

Indexed as

Chemokine CXCL10Signal TransductionFibrosisHumansLigandsReceptors, CXCR3Chemokine CXCL10CXCR3 protein, humanLigandsReceptors, CXCR3CXCL10CXCL11CXCL9CXCR3endothelial cellfibroblastfibrosispericyte

Identifiers

PMID33145014
PMCPMC7590900
OpenAlexW3091192076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.